Missing Script

Get updates

Evidence Explorer · MS-N298 · Nutrition and dietary patterns · Appraised November 10, 2026

An open-label randomized trial found that adding an oral nutrition supplement to dietary education improved weight and BMI versus education alone. Albumin and inflammatory measures did not differ, and 21 of 108 participants did not complete the study.

Evidence at a glance

  • Population: 108 adults with lung or gynecologic cancer were assigned; 87 completed the trial.
  • Intervention: oral nutrition supplementation plus dietary education versus dietary education alone.
  • Reported result: weight increased by 1.68 ± 3.96 kg and BMI by 0.86 ± 1.96 kg in the intervention arm while the control arm lost weight.
  • Other findings: anemia was reported in 60% versus 80.9%; albumin and inflammatory status did not differ significantly.
  • Evidence label: short-term nutritional-status signal; tumor response, recurrence and survival were not studied.
  • Evidence label: Positive weight signal; substantial attrition.

What was studied

Both groups improved nutrition knowledge, which helps separate the supplement’s added effect from education alone. The open-label design makes expectancy and co-intervention effects possible.

Weight gain can be valuable during treatment, but weight alone does not show whether muscle, edema or fat changed. The anemia comparison also needs caution because the intervention was not a replacement for diagnostic work-up or evidence-based anemia treatment.

What this evidence cannot establish

Completion was 81%, reasons and group-specific attrition were not fully available in the abstract, and the populations and treatments were heterogeneous. Formula, dose, adherence, adverse events, funding and allocation methods were not fully verified because this appraisal was abstract-level.

Safety and practical context

Formula selection should account for diabetes, renal function, fluid balance, constipation or diarrhea, swallowing and food-drug timing. Unexplained anemia needs evaluation rather than reliance on a nutrition product. Severe undernutrition requires refeeding-risk assessment and closer monitoring.

Questions for the care team

  • What was the supplement formulation and daily dose, and how consistently was it taken?
  • Did the weight difference reflect muscle, fat, fluid or a mixture?
  • What explains anemia, and does it require iron, B12, folate, bleeding or marrow evaluation?

Sources and identifiers

Funding and conflicts: The abstract lists academic and clinical-trial-company affiliations. Product provision, sponsor role and author conflicts were not fully reported in the accessible source and are marked not verified.

Source access and dates: Primary reports, registries and official guidance available through the links above were checked November 10, 2026. Last literature search November 10, 2026. Fields unavailable from accessible full text are labeled not reported or not verified rather than assumed absent.

Educational evidence summary, not individualized medical advice. Restrictive diets or supplements should not replace established cancer treatment or adequate nutrition. Symptom, weight, biomarker, laboratory, imaging, pathology or animal findings do not by themselves establish tumor control, recurrence prevention or longer survival.